Imiquimod attenuates airway inflammation and decreases the expression of thymus and activation regulated chemokine in allergic asthmatic mice.
Respiratory Department of Internal Medicine, First Affiliated Hospital of Nanjing Medical University, Nanjing 210029, China.
Shu-xian
SX
Jin
Kai-sheng
KS
Yin
Tao
T
Bian
Pei-li
PL
Sun
D000634:Aminoquinolines / Q000494:pharmacology* / Q000627:therapeutic use; D000818:Animals; D001249:Asthma / Q000188:drug therapy* / Q000276:immunology / Q000473:pathology; D001992:Bronchoalveolar Lavage Fluid / Q000166:cytology; D002452:Cell Count; D054414:Chemokine CCL17; D054422:Chemokine CCL22; D019742:Chemokines, CC / Q000032:analysis* / Q000235:genetics; D016207:Cytokines / Q000096:biosynthesis; D005434:Flow Cytometry; D000077271:Imiquimod; D015847:Interleukin-4 / Q000037:antagonists & inhibitors; D008297:Male; D051379:Mice; D008807:Mice, Inbred BALB C; D012333:RNA, Messenger / Q000032:analysis; D050800:STAT6 Transcription Factor / Q000032:analysis / Q000037:antagonists & inhibitors / Q000235:genetics; D015398:Signal Transduction / Q000187:drug effects
D000634:Aminoquinolines; C499538:Ccl17 protein, mouse; C515483:Ccl22 protein, mouse; D054414:Chemokine CCL17; D054422:Chemokine CCL22; D019742:Chemokines, CC; D016207:Cytokines; D012333:RNA, Messenger; D050800:STAT6 Transcription Factor; D015847:Interleukin-4; D000077271:Imiquimod